TEVA NEUROSCIENCE Trademark

Trademark Overview

On Thursday, June 7, 2001, a trademark application was filed for TEVA NEUROSCIENCE with the United States Patent and Trademark Office. The USPTO has given the TEVA NEUROSCIENCE trademark a serial number of 76268515. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Tuesday, August 13, 2024. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The TEVA NEUROSCIENCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system disorders
teva neuroscience

General Information

Serial Number76268515
Word MarkTEVA NEUROSCIENCE
Filing DateThursday, June 7, 2001
Status710 - CANCELLED - SECTION 8
Status DateTuesday, August 13, 2024
Registration Number2730118
Registration DateTuesday, June 24, 2003
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 23, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system disorders
Translation of Words in MarkThe English translation of the word "TEVA" in the mark is "nature".
NOT AVAILABLE"NEUROSCIENCE"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateTuesday, August 13, 2024
Primary Code005
First Use Anywhere DateSaturday, June 30, 2001
First Use In Commerce DateSaturday, June 30, 2001

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090

Trademark Events

Event DateEvent Description
Monday, February 4, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 10, 2001ASSIGNED TO EXAMINER
Friday, August 17, 2001NON-FINAL ACTION MAILED
Monday, May 6, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 3, 2002NOTICE OF PUBLICATION
Tuesday, July 23, 2002PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 29, 2003ASSIGNED TO EXAMINER
Thursday, March 27, 2003TEAS STATEMENT OF USE RECEIVED
Thursday, March 27, 2003USE AMENDMENT FILED
Saturday, April 26, 2003STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 1, 2003ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 24, 2003REGISTERED-PRINCIPAL REGISTER
Thursday, April 10, 2008CASE FILE IN TICRS
Friday, May 22, 2009TEAS SECTION 8 & 15 RECEIVED
Friday, May 29, 2009ASSIGNED TO PARALEGAL
Thursday, June 11, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, June 13, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 13, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 13, 2013TEAS SECTION 8 & 9 RECEIVED
Wednesday, June 26, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 26, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, June 26, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, June 26, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, January 18, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 18, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Tuesday, August 13, 2024CANCELLED SEC. 8 (10-YR)
Tuesday, August 13, 2024NOTICE OF CANCELLATION SEC. 8 EMAILED
Friday, June 24, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, July 20, 2023TEAS SECTION 8 & 9 RECEIVED

Related Keywords

neuroscience teva system disorders nervous central preparations treatment pharmaceutical